SGLT-2 inhibitors as second-line therapy in type 2 diabetes
Research output: Contribution to journal › Comment/debate
Colleges, School and Institutes
- Centre for Endocrinology, Diabetes, and Metabolism (CEDAM); School of Clinical and Experimental Medicine; University of Birmingham; Institute of Biomedical Research; UK
- Department of Diabetes and Endocrinology
- Birmingham Heartlands Hospital, Birmingham, UK.